We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00209677
Recruitment Status : Suspended (

Unfortunately, other Phase III clinical Study (GEM+S-1 vs GEM vs S-1) have been started in Japan.


First Posted : September 21, 2005
Last Update Posted : November 1, 2007
Hokkaido University Hospital
Information provided by:
Hokkaido Gastrointestinal Cancer Study Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Primary Completion Date : No date given
  Estimated Study Completion Date : December 2007